2m 2m 2m 2m 2m 2m 2m
Biocryst Pharm (BCRX)
NASDAQ
$7.79+$0.04 (+0.45%)
Price as of Oct 22, 2026 7:30 PM EDT- $2.0BMarket Cap
- 9.46%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Biocryst Pharm (BCRX)
$7.79+$0.04 (+0.45%)
BCRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.75 | ||
Change | -$0.19 (-2.39%) | ||
Open | $8.04 | ||
High | $8.05 | ||
Low | $7.73 | ||
Previous Close | $7.94 | ||
Volume | 5,034,035 | ||
30-Day Average Volume | 5,258,181 | ||
1-Week Change | -3.73% | ||
1-Month Change | -11.53% | ||
1-Year Change | 9.46% | ||
3-Year Change | 31.80% | ||
5-Year Change | -46.95% | ||
Fundamentals | |||
Shares Outstanding | 255.5M | ||
Total Assets | $557.9M | ||
Market Cap | $2.0B | ||
Enterprise Value | $2.2B | ||
Period: QTR TTM FY | |||
Revenue | $157.5M | ||
Net Income | $78.4M | ||
Free Cash Flow | $104.1M | ||
EBIT | $87.8M | ||
EBITDA | $87.8M | ||
Net Working Capital | $275.8M | ||
EPS | $0.30 | ||
Enterprise Value/EBITDA | 25 | ||
Enterprise Value/Revenue | 14 | ||
P/B | -4 | ||
P/E | 26 | ||
PEG | 0 | ||
Price/Free Cash Flow | 19 | ||
Price/Operating Cash Flow | 19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue